Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lara Smrdel"'
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: Carfilzomib is a second-generation proteasome inhibitor (PI) used for combination therapy with dexamethasone and/or lenalidomide in patients with relapsed or refractory multiple myeloma. Reports indicate that PIs have a unique toxicity pr
Externí odkaz:
https://doaj.org/article/84ab65e7807a4d0583ee1ff3a39499c8
Autor:
Levente Kollár, Martina Gobec, Matic Proj, Lara Smrdel, Damijan Knez, Tímea Imre, Ágnes Gömöry, László Petri, Péter Ábrányi-Balogh, Dorottya Csányi, György G. Ferenczy, Stanislav Gobec, Izidor Sosič, György M. Keserű
Publikováno v:
Cells, Vol 10, Iss 12, p 3431 (2021)
Constitutive- and immunoproteasomes are part of the ubiquitin–proteasome system (UPS), which is responsible for the protein homeostasis. Selective inhibition of the immunoproteasome offers opportunities for the treatment of numerous diseases, inclu
Externí odkaz:
https://doaj.org/article/ad5fe72dbb704a139bb1f472787654f3